Cargando…
CD4(+) CTLs Act as a Key Effector Population for Allograft Rejection of MSCs in a Donor MHC-II Dependent Manner in Injured Liver
Mesenchymal stromal/stem cells (MSCs) have been considered an attractive source of cytotherapy due to their promising effects on treating various diseases. Allogeneic MSCs (allo-MSCs) are extensively used in clinical trials due to their convenient preparation and credible performance. Traditionally,...
Autores principales: | Shen, Shuang, Li, Yuanhui, Jin, Mengting, Fan, Dongdong, Pan, Ruolang, Lin, Aifu, Chen, Ye, Xiang, Lixin, Zhao, Robert Chunhua, Shao, Jianzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662282/ https://www.ncbi.nlm.nih.gov/pubmed/36465184 http://dx.doi.org/10.14336/AD.2022.0314 |
Ejemplares similares
-
Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection
por: Amouzegar, Afsaneh, et al.
Publicado: (2017) -
Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood
por: Beloki, Lorea, et al.
Publicado: (2015) -
Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
por: Cruz-Guilloty, Fernando, et al.
Publicado: (2009) -
T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity
Publicado: (1990) -
Celiac CTLs change their stripes
por: Van Epps, Heather L.
Publicado: (2006)